NSE · KRSNAA
Krsnaa Diagnostics Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹240 Cr with net profit ₹25 Cr — a 10.56% net margin, versus 7.51% the period before.
Shareholding
As of 2026-09-30
- Promoter27.11%
- Public54.54%
- FII3.84%
- DII14.5%
50,671 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.81× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #29 of 87 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,21,441 Cr | 53.63 | 11.45 | 21.14% | 8.12% |
| Max Healthcare Institute Ltd. | ₹90,909 Cr | 64.02 | 8.02 | 12.18% | 15.1% |
| Manipal Health Enterpri Limited | ₹85,065 Cr | 90.7 | 5.18 | 10.59% | 7.81% |
| Aster DM Quality Care Ltd. | ₹62,142 Cr | 160.2 | 14.77 | 8.48% | 6.54% |
| Fortis Healthcare Ltd. | ₹57,898 Cr | 54.27 | 5.53 | 9.91% | 10.48% |
| Narayana Hrudayalaya Ltd. | ₹38,890 Cr | 42.98 | 7.77 | 17.17% | 8.36% |
| Global Health Limited | ₹37,309 Cr | 57.62 | 8.63 | 14.3% | 12.24% |
| Dr. Lal Path Labs Ltd. | ₹33,066 Cr | 54.59 | 12.03 | 21.32% | 19.29% |
| Krishna Institute of Medical Sciences Ltd. | ₹30,366 Cr | 149.38 | 7.72 | 5.4% | 4.62% |
| Dr. Agarwal's Health Care Limited | ₹16,371 Cr | 111.04 | 7.32 | 8.04% | 7.61% |
| Krsnaa Diagnostics Ltd.(this company) | ₹1,541 Cr | 15.71 | 1.48 | 9.45% | 11.15% |
AI analysis
AI-generated · google/gemini-2.5-flashKrsnaa Diagnostics Ltd. is listed on the Indian markets with a market capitalization of Rs 1774 Cr. The company reported a revenue of Rs 742.7 Cr and an EPS of Rs 25.65. The book value per share is Rs 274.65.
Positives
- +The debt-to-equity ratio is 0.21, indicating a low level of debt.
- +No promoter shares are reported as pledged, with promoter pledge at 0%.
Negatives
- −Promoter shareholding has decreased from 66.19% in May 2021 to 27.11% in June 2026.
- −The number of shareholders has decreased from 87,313 in August 2021 to 53,625 in June 2026.
Financial performance
In the fiscal year ending March 2025, Krsnaa Diagnostics Ltd. reported a revenue of Rs 742.695 Cr and a net profit of Rs 77.608 Cr. Quarterly results show a revenue of Rs 192.6 Cr and a net profit of Rs 41.72 Cr for the quarter ending March 2026.
Profitability & returns
The company's Return on Equity (ROE) is 9.7%, and its Return on Capital Employed (ROCE) is 10.42%. The Price-to-Earnings ratio stands at 30.62. The Earnings Per Share (EPS) for the latest reported period is Rs 25.65.
Balance sheet
Krsnaa Diagnostics Ltd. has a debt-to-equity ratio of 0.21. The book value per share is Rs 274.65. The company has a 52-week high of Rs 894.4 and a 52-week low of Rs 515.
Ownership & pledges
As of June 30, 2026, the promoter holding in Krsnaa Diagnostics Ltd. is 27.1146%. Public shareholding is 54.0877%. There are no reported promoter share pledges.
Shareholding changes
Promoter holding has decreased from 66.1872% in May 2021 to 27.1146% in June 2026. Public shareholding has increased from 33.8128% in May 2021 to 54.0877% in June 2026. The number of shareholders has decreased from 87,313 in August 2021 to 53,625 in June 2026.
Data as of — price: 2026-11-07 · financials: Sep 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.